Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S, a leading global healthcare company, has actively pursued its share repurchase program, buying back B shares worth DKK 2.2 billion between May and August 2024. This initiative is part of a larger DKK 20 billion buyback plan set to run over 12 months starting February 2024. As of July 19, the company has acquired 10,619,037 B shares at an average price of DKK 878.31 each, totaling DKK 9.3 billion in transaction value.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
